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Sumoylated hnRNPA2B1 controls the sorting of
miRNAs into exosomes through binding to speciﬁc
motifs
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Exosomes are released by most cells to the extracellular environment and are involved in
cell-to-cell communication. Exosomes contain speciﬁc repertoires of mRNAs, microRNAs
(miRNAs) and other non-coding RNAs that can be functionally transferred to recipient cells.
However, the mechanisms that control the speciﬁc loading of RNA species into exosomes
remain unknown. Here we describe sequence motifs present in miRNAs that control their
localization into exosomes. The protein heterogeneous nuclear ribonucleoprotein A2B1
(hnRNPA2B1) speciﬁcally binds exosomal miRNAs through the recognition of these motifs
and controls their loading into exosomes. Moreover, hnRNPA2B1 in exosomes is sumoylated,
and sumoylation controls the binding of hnRNPA2B1 to miRNAs. The loading of miRNAs into
exosomes can be modulated by mutagenesis of the identiﬁed motifs or changes in
hnRNPA2B1 expression levels. These ﬁndings identify hnRNPA2B1 as a key player in miRNA
sorting into exosomes and provide potential tools for the packaging of selected regulatory
RNAs into exosomes and their use in biomedical applications.
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E
xosomes are 50- to 300-nm-diameter vesicles secreted by
most cells to the extracellular environment through fusion
with the plasma membrane of endosomic compartments
called multivesicular bodies1. Exosomes have been shown to
contain RNAs, including mRNAs, microRNAs (miRNAs) and
other non-coding RNAs2. These exosomes can be transferred to
recipient cells, where shuttled RNA can be functional3–7. The
functional relevance of miRNA-containing exosomes transfer has
been reported both in vitro and in vivo8,9. Exosomes have
potential uses as biomarkers10,11, vaccines12 and vehicles for gene
therapy13 and have been modiﬁed to facilitate the delivery of
cargo into speciﬁc target cells14. Recent evidence suggests that the
miRNA repertoires of exosomes differ from those of their
parental cells5,15,16; however, the mechanisms that control the
selective sorting of RNA into exosomes are still unknown.
Here we identify short sequence motifs over-represented in
miRNAs (EXOmotifs) that guide their loading into exosomes
and show that their directed mutagenesis enables modulation
of miRNA cargo in these vesicles. Heterogeneous nuclear
ribonucleoprotein A2B1 (hnRNPA2B1) is a ubiquitously
expressed RNA-binding protein that controls the transport and
subcellular localization of speciﬁc mRNAs in neurons17 and the
trafﬁcking of HIV genomic RNA18. We report that hnRNPA2B1
binds a speciﬁc subset of miRNAs through their EXOmotifs and
controls their loading into exosomes. Moreover, hnRNPA2B1 in
exosomes is sumoylated, and this post-translational modiﬁcation
controls hnRNPA2B1–miRNA binding.
Results
Speciﬁc repertoires of miRNAs are sorted into exosomes. To
assess whether some RNAs are speciﬁcally sorted into exosomes,
we conducted a microarray analysis of activation-induced chan-
ges in the miRNA and mRNA proﬁles of primary T lymphoblasts
and their exosomes (Fig. 1a and Supplementary Data 1, data
publicly available at Gene Expression Omnibus through GEO
Series accession number GSE50972). Exosome sample quality was
assessed using western blot (Supplementary Fig. S1a) and electron
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Figure 1 | The sequence of miRNAs controls their localization into exosomes. (a) Microarray analysis of exosomal and cellular miRNAs from human
primary T lymphocytes in resting and activated (PMA and ionomycin) conditions. The panel shows the heatmap of the per-row normalized expression
levels of selected miRNAs differentially expressed in cells (CL) versus exosomes (EXOs) in resting (REST) or activated conditions (ACT). (b) Upper panel:
Venn diagrams based on miRNA microarray results showing that activation-induced changes in miRNA proﬁle are not the same in T cells and their
derived exosomes. Lower panel: Venn diagrams based on miRNA microarray results showing that some miRNAs are always speciﬁcally sorted into
exosomes (EXOmiRNAs, left panel) or speciﬁcally retained in cells (CLmiRNAs, right panel), independently of the activation state of the T cell.
(c) Cladogram showing the multiple alignment of mature sequences of 30 EXOmiRNAs (red) and 42 CLmiRNAs (blue), revealing that miRNA clustering
coincides with preferential localization in exosomes or cells. (d) Over-represented motifs in EXOmiRNAs (EXOmotifs, left panels) and CLmiRNAs
(CLmotifs, right panels); ZOOPS model was used. For each data set, the remaining miRNAs annotated in Ensembl was used as background. A Markov
model of order 0 was assumed for the background sequences. E-value o104.
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microscopy (Supplementary Fig. S1b). Microarray analysis
showed that in most cases the miRNAs modulated upon activa-
tion are not the same in cells and exosomes, either for upregu-
lated or for downregulated miRNAs (Fig. 1b, top panels). Thus,
miRNAs whose expression levels increase in T cells upon acti-
vation are not signiﬁcantly increased in exosomes and vice versa
(Supplementary Data 1). A similar trend was observed for
mRNAs (Supplementary Fig. S1c). This lack of concordance
between the activation-regulated miRNA and mRNA proﬁles of
cells and exosomes indicates that miRNA and mRNA loading
into exosomes is not a passive process. Several miRNAs were
more highly represented in exosomes than in cells (such as miR-
575, miR-451, miR-125a-3p, miR-198, miR-601 and miR-887;
Fig. 1a), and in most cases this difference is maintained under
resting and activated conditions (Fig. 1b, lower left panel).
Similarly, most miRNAs that are more highly represented in cells
than in exosomes (such as miR-17, mir-29a, let-7a, miR-142-3p,
miR-181a and miR-18a; Fig. 1a) maintain this tendency inde-
pendently of the activation state of the cell (Fig. 1b, lower right
panel). Some miRNAs are thus speciﬁcally sorted into exosomes
(EXOmiRNAs), whereas others are speciﬁcally retained in cells
(CLmiRNAs). Similar results were obtained for mRNA
(Supplementary Fig. S1c). Together, these data suggest the exis-
tence of mechanisms that control the active sorting of RNAs into
exosomes.
miRNAs contain motifs that control their sorting in exosomes.
To investigate sequence differences, we performed a multiple
alignment analysis (ClustalW) of the mature sequences of 30
EXOmiRNAs and 42 CLmiRNAs. For this analysis, we used
EXOmiRNAs and CLmiRNAs that show differential expression
in cells with respect to exosomes in both primary T cells (data
from the current study) and the leukemic Jurkat T-cell line (data
previously published in Mittelbrunn et al.5 and publicly available
at the Gene Expression Omnibus through GEO Series accession
number GSE27997), and maintain this tendency under resting
and activated conditions. The alignment cladogram grouped
mature miRNAs according to their tendency to be localized in
cells (CLmiRNAs, blue) or exosomes (EXOmiRNAs, red)
(Fig. 1c). Moreover, paralogous miRNAs, which have similar
sequences but differ in their chromosomal localization (and
therefore in their transcription levels), always showed the same
tendency to be localized in exosomes or cells (Supplementary
Data 1). In contrast, mature miRNA complementary chains
derived from the same pre-miRNA, which are therefore expressed
at similar levels but have different sequences, can differ in their
tendency for cell versus exosome localization (Supplementary
Data 1). These data together suggest that the sequence of
mature miRNAs is important for determining their sorting into
exosomes.
An unbiased search for speciﬁc motifs detected two motifs
signiﬁcantly over-represented in EXOmiRNAs (EXOmotifs), and
three motifs signiﬁcantly over-represented in CLmiRNA
sequences (CLmotifs) (Fig. 1d). The EXOmotif GGAG and the
CLmotif UGCA occur in the 30 half of the miRNA sequence in
75% and 66.6% of cases, respectively. The other CLmotifs appear
in the 50 half, and the remaining EXOmotif does not occur at a
characteristic position. To ascertain whether these motifs are
important for miRNA sorting, we cloned the CLmiRNA miR-17
and the EXOmiRNA miR-601 into retroviral vectors and then
performed directed mutagenesis to convert the CLmotif of miR-
17 into an EXOmotif and, conversely, the EXOmotif of miR-601
into a CLmotif (Fig. 2a). Differential overexpression of wild-type
versus mutated miRNAs was assessed using RT–PCR with
locked nucleic acid (LNA)-speciﬁc primers, allowing us to
discriminate between the wild-type and mutated miRNAs
(Supplementary Fig. S2). miRNA levels in Jurkat T cells and
their exosomes were analysed by absolute quantitative PCR,
normalizing against synthetic RNAs added exogenously to all
samples. In accordance with microarray data (Supplementary
Table S1), the EXOmiRNAs miR-198 and miR-601 had a higher
EXO/CL ratio than the CLmiRNAs miR-17 and miR-18a
(Fig. 2b). However, conversion of the miR-17 CLmotif into an
EXOmotif (miR-17mut) resulted in a higher EXO/CL ratio
(Fig. 2c, left panel), and in the complementary experiment
conversion of the EXOmotif in miR-601 into a CLmotif (miR-
601mut) decreased the EXO/CL ratio (Fig. 2c, right panel). These
data thus indicate that speciﬁc short motifs present in miRNAs
determine the sorting of miRNAs into exosomes.
hnRNPA2B1 controls the loading of EXOmiRNAs into
exosomes. To investigate the molecular machinery that controls
the sorting of speciﬁc miRNAs into exosomes, we screened for
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Figure 2 | Loading of miRNAs into exosomes is controlled by short
motifs. (a) Sequences of wild-type miRNAs and their mutated versions
used in this study. Mutated miR-17 has an EXOmotif instead of its
characteristic CLmotif, whereas mutated miR-601 has a CLmotif instead of
its EXOmotif. (b) EXO/CL ratio of each miRNA, obtained by dividing the
number of copies in exosomes by the number of copies in cells. Copy
number was determined using absolute quantitative PCR. Error bars
represent s.d. (n¼4). One-way ANOVA; P-value o0.01. (c) Left panel:
EXO/CL ratio of mutated miR-17 and endogenous (wild-type) miR-17 and
miR-18. Right panel: EXO/CL ratio of mutated miR-601 and endogenous
(wild-type) miR-601 and miR-18a. Error bars represent s.d. (n¼ 3).
Student’s t-test; *P-value o0.05.
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proteins present in exosomes that speciﬁcally bind EXOmiRNAs.
Extracts from human primary T-cell exosomes were incubated
with streptavidin beads coated with either a biotinylated EXO-
miRNA (miR-198) or a biotinylated CLmiRNA (miR-17), and
pulled down proteins were subjected to high-throughput identi-
ﬁcation using mass spectrometry (Supplementary Data 2). As
negative controls, we used non-coated and poly-A RNA-coated
streptavidin beads. A group of RNA-related proteins was pre-
cipitated with one or both miRNAs, but not with the negative
controls. Functional analysis of the precipitated proteins revealed
a predominant association with biological functions related
to RNA-post-transcriptional modiﬁcations (Supplementary
Table S1). The set of precipitated proteins included several
heterogeneous nuclear ribonucleoproteins (hnRNPs). Among
them, hnRNPA2B1 and hnRNPA1 seemed to bind only the
EXOmiRNA, showing no detectable binding to CLmiRNA or
the poly-A control (Fig. 3, Table 1, Supplementary Fig. S3 and
Supplementary Data 2). hnRNPA2B1 is an ubiquitous protein
that has been shown to regulate mRNA trafﬁcking to axons in
neural cells17. Moreover, the mRNA transport function of
hnRNPA2B1 in neurons is mediated by its binding to a 21-nt
RNA sequence called RNA trafﬁcking sequence (RTS)19.
Interestingly, this sequence contains both of the EXOmotifs
identiﬁed here (Fig. 1d and Supplementary Fig. S4a).
HnRNPA2B1 is thus a good candidate regulator of EXOmiRNA
sorting to exosomes. The presence of hnRNPA2B1 in exosomes
was conﬁrmed using western blot of exosomes isolated with
ultracentrifugation and ﬂoated with centrifugation to equilibrium
density into a sucrose gradient (Supplementary Fig. S4b).
Although this is the most stringent method for exosome
puriﬁcation, we cannot rule out the presence of other extra-
cellular vesicles with similar size and density in these fractions.
Fluorescence-activated cell sorting (FACS) analysis showed that
hnRNPA2B1 ﬂuorescence is higher in permeabilized exosomes
than in non-permeabilized exosomes (Fig. 4a), indicating that the
protein locates inside the exosomes. Confocal analysis revealed
that hnRNPA2B1 is located mainly in the nucleus, but also in
cytoplasmic granules (Supplementary Fig. S4c,d). These data are
supported using western blot analysis of hnRNPA2B1 in T-cell
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Figure 3 | HnRNPA2B1 speciﬁcally binds EXOmiRNAs. Exosome extracts were incubated with streptavidin beads coated with either a biotinylated
EXOmiRNA (miR-198), a biotinylated CLmiRNA (miR-17) or a negative control (poly-A), and with non-coated beads (beads). The graphs represent the
extracted ion chromatogram traces of the monoisotopic peaks corresponding to the indicated peptides, identiﬁed from hnRNPA2B1or from a non-
speciﬁcally binding protein (nucleolin).
Table 1 | Summary of high-throughput mass spectrometry
analysis of miRNA-precipitated proteins.
CLmiRNA EXOmiRNA Poly-A Beads
hnRNPA2B1 0 4 0 0
hnRNPA1 0 2 0 0
hnRNPC 0 1 0 0
hnRNPU 1 3 0 0
RS4X 0 3 0 0
RS3 1 3 0 0
NUCL 6 9 8 0
CLmiRNA, miRNA sorted into cells, EXOmiRNA, miRNA sorted into exosomes; hnRNPA2B1,
heterogeneous nuclear ribonucleoprotein A2B1; hnRNPA1, heterogeneous nuclear
ribonucleoprotein A1; hnRNPC, heterogeneous nuclear ribonucleoprotein C; hnRNPU,
heterogeneous nuclear ribonucleoprotein U; RS4X, 40S ribosomal protein S4; RS3, 40S
ribosomal protein S3; NUCL, nucleolin; miRNA, micro RNA.
Exosome extracts were incubated with streptavidin beads coated with either a biotinylated
EXOmiRNA (miR-198), a biotinylated CLmiRNA (miR-17) or a negative control (poly-A), and
with non-coated beads (beads). The table represents the number of peptides of hnRNPA2B1,
hnRNPA1 and other related proteins that were identiﬁed in the precipitated fractions.
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subcellular fractions, which show that hnRNPA2B1 cytoplasmic
fraction is mainly associated with membranous organelles
(Supplementary Fig. S4e). Moreover, hnRNPA2B1 colocalizes in
the cytoplasm of cells with MVB markers such as ceramide20
(Supplementary Fig S5).
Speciﬁc binding of hnRNPA2B1 to miR-198 was veriﬁed with
immunoprecipitation of hnRNPA2B1 from exosome lysates
followed by qPCR of miRNAs; miR-198, but not miR-17, was
ampliﬁed from hnRNPA2B1 immunoprecipitates, demonstrating
speciﬁc binding of hnRNPA2B1 and miR-198 in exosomes in vivo
(Fig. 4b). The speciﬁc binding of hnRNPA2B1 and miR-198 was
conﬁrmed using electrophoresis mobility shift assay (Fig. 4c).
This binding was inhibited when the EXOmotif of miR-198 was
mutated (Fig. 4d), indicating that the binding of hnRNPA2B1 to
miR-198 is dependent on the presence of the EXOmotif.
HnRNPA2B1 also binds other EXOmiRNAs such as miR-601
(Fig. 4e).
In order to investigate the role of hnRNPA2B1 in the
packaging of miRNAs into exosomes, we assessed the effect of
silencing or increasing its expression on the EXO miRNA proﬁle
in Jurkat T cells (Supplementary Fig. S6a,b). HnRNPA2B1
silencing signiﬁcantly decreased the levels of the EXOmiRNA
miR-198 in exosomes but did not signiﬁcantly alter the levels of
the CLmiRNA miR-18a (Fig. 4f); in contrast, hnRNPA2B1
overexpression increased the levels of miR-198 in exosomes
without changing the levels of miR-18a (Fig. 4g). In the
overexpression experiments, the puriﬁcation method used to
recover exosomes was less stringent; therefore, it is possible that
we were also detecting exosome-independent secreted miRNAs.
These data indicate that hnRNPA2B1 controls the loading of
speciﬁc EXOmiRNAs into exosomes.
The loading of miRNAs is controlled by hnRNPA2B1
sumoylation. Western blot analysis of hnRNPA2B1 (Fig. 5a) and
hnRNPA1 (Supplementary Fig. S7a) from exosomes revealed a
higher molecular weight (m.w.) (B10–12 kDa more) in com-
parison with cells, suggesting that these proteins might be post-
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Figure 4 | HnRNPA2B1 binds EXOmiRNAs through EXOmotifs and is involved in their loading into exosomes. (a) FACS analysis of hnRNPA2B1 and
CD81 in exosome-coupled beads. Exosomes were coupled to aldehyde-sulfate beads, permeabilized or left intact and incubated with antibodies to
hnRNPA2B1 (middle panels) or CD81 (right panels) and secondary antibody. Exosome-coupled beads incubated with secondary antibody alone were used
as negative controls (left panels). (b) qPCR analysis of miRNAs contained in hnRNPA2B1 immunoprecipitates from exosome lysates, showing the speciﬁc
binding of miR-198 to hnRNPA2B1 in exosomes. Immunoprecipitation was performed with magnetic beads coated with anti-hnRNPA2B1 or anti-IgG1
control antibody. Data are presented relative to miR-17 content in control immunoprecipitates. Error bars represent s.d. (n¼ 2). (c) Electrophoresis mobility
shift assay showing the speciﬁc binding of miR-198 to hnRNPA2B1. Biotinylated miR-17, miR-198 or poly-A were incubated with or without puriﬁed human
hnRNPA2B1 as indicated. (d) Electrophoresis mobility shift assay showing the binding of hnRNPA2B1 to wild-type and mutated miR-198. Biotinylated
wild-type and mutated miR-198 were incubated with or without puriﬁed human hnRNPA2B1 as indicated. Numbers represent protein concentration
(ngml 1). (e) Electrophoresis mobility shift assay showing the binding of hnRNPA2B1 to miR-601. (f) qPCR analysis of miR-18a and miR-198 in exosomes
from control cells or cells silenced with siRNAs against hnRNPA2B1. Bars represent miRNA levels in exosomes (arbitrary units). Error bars represent s.d.
(n¼ 3). Student’s t-test; *P-value o0.001. (g) qPCR analysis of miR-18a and miR-198 levels in exosomes from control cells or cells overexpressing
hnRNPA2B1-GFP. Bars represent miRNA levels in exosomes (arbitrary units). Error bars represent s.d. (n¼ 3). Student’s t-test; *P-valueo0.01.
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translationally modiﬁed in exosomes. Several hnRNPs including
hnRNPA1 are known to attach to small ubiquitin-related modi-
ﬁer (SUMO)21, and the observed m.w. changes in exosomes are
consistent with sumoylation. Moreover, in silico analysis of the
hnRNPA2B1 protein sequence identiﬁed several predicted sites
for SUMO conjugation (Supplementary Fig. S7b). To assess
hnRNPA2B1 sumoylation, HEK293T cells were co-transfected
with SUMO-1 and hnRNPA2B1-GFP (green-ﬂuorescent protein)
or GFP plasmids. After GFP immunoprecipitation, SUMO-1 was
detected in cells transfected with hnRNPA2B1GFP but not in
cells transfected with GFP alone (Fig. 5b). Sumoylation of
hnRNPA2B1 was also demonstrated in T cells by the detection of
SUMO-1 after hnRNPA2B1 immunoprecipitation (Fig. 5c). To
conﬁrm whether the higher m.w. of exosomal hnRNPA2B1 was
because of sumoylation, we cultured Jurkat T cells in the presence
of the speciﬁc sumoylation inhibitor anacardic acid (AA)22
(Supplementary Fig. S7c). Whereas untreated exosomes
contained barely detectable amounts of low-m.w. hnRNPA2B1,
in the presence of AA the low-m.w. band could be readily
detected (Fig. 5d). These results indicate that the higher m.w. of
exosomal hnRNPA2B1 is because of sumoylation, and that
sumoylated hnRNPA2B1 is preferably sorted to exosomes.
Further analysis revealed that treatment with AA reduced the
levels of miR-198 in exosomes, whereas the levels of miR-17 and
miR-18 did not change (Fig. 5e). Moreover, hnRNPA2B1 IP-
qPCR experiments showed that there was less miR-198 bound to
hnRNPA2B1 when sumoylation was inhibited (Fig. 5f), while
exosome secretion or cell death did not change (Supplementary
Fig. S7d). These data indicate that hnRNPA2B1-mediated loading
of EXOmiRNAs into exosomes is controlled by the sumoylation
of the protein.
Discussion
In this report we identify short sequence motifs over-represented
in miRNAs commonly enriched in exosomes. These motifs
control the loading of these miRNAs into exosomes, and their
directed mutagenesis enables the modulation of miRNA cargo in
these vesicles.
The ability of short nucleotide sequences to guide the transport
of RNAs to different subcellular compartments has been reported
previously. For example, a 20-ribonucleotide stem-loop sequence
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was shown to direct the import of nuclear-encoded mRNAs
to mitochondria23, and the hexanucleotide terminal motif of
miR-29b was previously demonstrated to direct the nuclear
enrichment of this miRNA24. In addition, a 21-nucleotide
sequence in the 30 untranslated region (UTR) of the myelin
basic protein (MBP) mRNA was demonstrated to be necessary
and sufﬁcient for the transport of this transcript along axons and
its subsequent localization in the myelin compartment25. This
sequence, known as RTS, binds the protein hnRNPA2B1, which is
required for MBP transport and localization17,19. Our proteomic
analyses detected the speciﬁc binding of hnRNPA2B1 to the
EXOmiRNA miR-198, which shares with the RTS the two motifs
we found to be over-represented in EXOmiRNAs. We have
demonstrated that hnRNPA2B1, which is present in exosomes,
binds the EXOmiRNA directly and controls its loading into these
microvesicles. In addition, hnRNPA2B1 in exosomes is
preferentially sumoylated, and this sumoylation is important for
the loading of EXOmiRNAs into exosomes. HnRNPA1 might
work in a similar way, since it speciﬁcally binds the EXOmiRNA
miR-198 and has been reported to be sumoylated21. Interestingly,
hnRNPA1 has been implicated in miRNA biogenesis26. Unlike
ubiquitination, sumoylation does not target proteins to
proteasome degradation; instead, conjugation of SUMO has
been shown to affect protein functions by altering their stability,
subcellular localization or their ability to interact with other
proteins27. Interestingly, modiﬁcation of protein properties by
sumoylation has been reported to affect mRNA trafﬁcking in
axons by promoting the binding of the La protein to dynein over
the binding to kinesin28. SUMO conjugation has been demon-
strated to affect several hnRNPs21, whose functions can also be
modiﬁed by other post-translational modiﬁcations such as
phosphorylation. In this regard, the interaction of hnRNPA2B1
and hnRNPF with MBP mRNA can be modulated through
phosphorylation by src-kinases29,30. Moreover, sumoylation and
phosphorylation are associated events in many pathways; for
instance, FAK protein sumoylation enables its interaction with
src-kinases, resulting in phosphorylation and full activation of the
protein31.
The function of hnRNPA2B1 in transporting RNA to exosomes
is probably dependent on its ability to interact with cytoskeletal
components. Indeed, there is evidence that in neurons hnRNPA2B1
partly regulates motor activity through indirect contacts with
microtubules32, and monomeric or short oligomeric actin has been
shown to associate with a subset of hnRNPs, including
hnRNPA2B133. HnRNPA2B1 was demonstrated to control HIV
RNA trafﬁcking and viral assembly18, and given the convergences
between HIV virus production and exosome biogenesis and
secretion34,35, it is conceivable that both phenomena share
common RNA transport mechanisms. In addition, hnRNPA2B1
and hnRNPA1 contain prion-like domains36 that correspond to the
‘low-complexity sequences’ found in several hnRNPs that are
essential determinants of RNA granule assembly37. Prion-like
domains are also involved in hnRNPA2B1 recruitment to stress
granules36, which are cytoplasmatic ribonucleoprotein granules
containing nontranslated mRNA and translation repressors38.
Finally, hnRNPA2B1 has also been described to interact with
TDP-43 (ref. 39), another component of RNP granules that has
been implicated in miRNA biogenesis40.
Certain conserved RNA motifs are commonly present in
speciﬁc secondary structures called RNA tetraloops, which
usually serve as recognition sites for interaction with proteins
or other RNA structural elements. The GGAG tetraloop has been
reported to mediate the binding of HIV nucleocapsid protein to
genomic cRNA packaging signals41, and also mediates RNA–
protein interactions in the signal recognition particle complex42.
It would be interesting to study whether the GGAG EXOmotif
occurs in speciﬁc secondary structures in EXO miRNAs and
whether these putative structures are essential for the binding to
hnRNPA2B1.
Cells have recently been shown to communicate with each other
through the transfer of miRNA-loaded exosomes5–9. For example,
monocyte-derived exosomes deliver miR-150 to endothelial cells
and enhance their migration by reducing c-myb expression9.
The miRNA content of exosomes plays a critical role in this type
of cell–cell communication and determines the fate of the
recipient cell. Thus, exosomes derived from the bone marrow
mesenchymal stromal cells of myeloma patients promote
tumour growth, and this effect depends on the content of
miR-15a in exosomes8. HnRNPA2B1-mediated miRNA loading
into exosomes is probably important for this novel mode of
cell–cell communication. However, the functional relevance of
hnRNPA2B1 and how it is regulated in different cell situations
is still not understood. Another possible function for
hnRNPA2B1-dependent export of miRNAs in exosomes is to
provide a mechanism for eliminating undesired miRNAs.
Our ﬁndings show that sumoylated hnRNPA2B1 directs the
loading of certain miRNAs into exosomes through recognition of
speciﬁc short motifs (Fig. 6). These RNA motifs may be useful for
the artiﬁcial loading of selected small regulatory RNAs into
exosomes and may prove to be suitable tools for the engineering
of exosomes for gene therapy. These ﬁndings represent a major
advance in our understanding of how miRNAs are loaded into
exosomes and exported from cells.
Methods
Cell culture. Human peripheral blood mononuclear cells were isolated from buffy
coats from healthy donors by separation on a biocoll gradient (Biochrom). After
30min of adhesion step at 37 C, non-adherent cells were cultured 2 days in the
presence of phytohemagglutinin (5 mgml 1) to induce lymphocyte proliferation.
To obtain T lymphoblasts, IL-2 (50Uml 1) was added to the medium every
2 days for a time period of 5 days. When indicated, T lymphoblasts were
activated with phorbol myristate acetate (PMA) (50 ngml 1) plus ionomycin
(500 ngml 1). The human Jurkat-derived T-cell line J77cl20 (TCR Val. 2 Vb8)
was cultured in RPMI (Sigma) containing 10% fetal bovine serum (FBS; Invitro-
gen). Jurkat cells were transduced by retroviral infection to overexpress miR-17mut
or miR-601mut and selected with puromycin (4 mgml 1). HEK-293T cells were
cultured in DMEM (Sigma) containing 10% FBS. All the procedures and
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Figure 6 | Diagram representing the proposed mechanism of the sorting
of miRNA into exosomes through binding to hnRNPA2B1. PM: plasma
membrane, MVB: multivesicular bodies, S: SUMO, A2B1: hnRNPA2B1.
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techniques developed within this work have been performed with the approval of
the Ethical Committee from Centro Nacional de Investigaciones Cardiovasculares
Carlos III, with the required ethical authorization and following both Spanish and
the European Union rules and laws.
Exosome puriﬁcation. Donor cells were cultured in RPMI-1640 supplemented
with 10% FBS (depleted of bovine exosomes by overnight centrifugation at
100,000 g). Exosomes were prepared from cell supernatants by a series of cen-
trifugation and ﬁltration steps3; brieﬂy, cells were centrifuged (320 g, 5min) and the
supernatant ﬁltered through 0.22-mm membranes. Exosomes were pelleted using
ultracentrifugation at 100,000 g for 60min at 4 C (Optima L-100 XP, Beckman
Coulter). When indicated, exosomes were overlaid with a linear sucrose gradient
(2.5–0.4M sucrose in phosphate-buffered saline (PBS)) and ﬂoated into the
gradient using centrifugation for 16 h at 120,000 g. For the analysis of miRNA
proﬁle in cells overexpressing hnRNPA2B1, exosomes were isolated with
ExoQuick-TC Exosome Precipitation Solution (SBI).
Microarray analysis. Primary human T lymphoblasts were obtained from eight
donors and total RNA was isolated from cells and derived exosomes before and
after activation with PMA (50 ngml 1) plus ionomycin (500 ngml 1). Cell
activation was assessed using ﬂow cytometry analysis of CD69 upregulation. The
large and small RNA proﬁles of cells and exosomes were assessed on an Agilent
2100 Bioanalyzer (Agilent) by analysis of total RNA (RNA nano chips) and small
RNA (small RNA chips). Microarray experiments were performed using the
human miRNA and mRNA microarrays from Agilent. Arrays were used to analyse
two RNA pools from four healthy donors of primary human resting and activated
T lymphoblasts and their exosomes. Array data for mRNA and miRNA were
normalized using the quantiles method (similar results were obtained for miRNA
data using vsn2 normalization). After normalization, only those miRNA probes
present in at least two samples and with an average expression above the 20th
percentile of all average expressions were considered for further analysis (316
miRNAs). Similarly, probes from genes included in the mRNA array were excluded
from the analysis unless they exhibited a strong signal and an acceptable ﬂag in all
replicates of at least one studied condition, and these probes were additionally
required to present some changes across samples (CV 45%). Linear models43 as
implemented in the limma Bioconductor package were then used to ﬁnd miRNAs
and genes differentially expressed between the contrasts of interest. We considered
differentially expressed those mRNAs and miRNAs with an adjp r0.05.
Multiple alignment and over-represented motif analysis. Multiple sequence
alignment was performed with ClustalW (gap open 12, gap extension 3). The
cladogram was generated with the Geneious software. An unbiased search to
identify over-represented motifs was performed using the bioconductor package
COSMO44. COSMO results were replicated using Improbizer. We ran the ZOOPS
(zero-or-one-occurrence) model to ﬁnd over-represented 4–8 nucleotide-long
motifs. For each data set, the remaining miRNAs annotated in Ensembl was used as
background. A Markov model of order 0 was assumed for the background
sequences. All motifs showed an E-value o10 4.
Cloning and directed mutagenesis. hsa-miR-17 (forward primer: 50-CCCTTTCT
CGAGCCCCATTAGGGATTATGCTG-30 , reverse primer: 50-GGGAAAGAATT
CAGATGCACCTTAGAACAAAAAGC-30) and hsa-miR-601 (forward primer:
50-CCCTTTCTCGAGGAGCACAGCCCTCAGTCTCT-30 , reverse primer: 50-GG
GAAAGAATTCTCCAACTCTGACTGGGACCT-30) were cloned in pGEM-T
(Promega) and subsequently in pLVX-AcGFP1-C1 (miR-17) or pMSCV-GFP
(miR-601) in XhoI and EcoRI restriction sites. Site-directed mutagenesis was
performed with the QuickChange Site-Directed mutagenesis kit (Stratagene).
Constructs were sequence-veriﬁed.
Lentiviral infection. Jurkat cells overexpressing miRNA-17mut or miRNA-
601mut were generated by retroviral infection. Brieﬂy, HEK293T cells were co-
transfected (Lipofectamine 2000, Invitrogen) with plasmids encoding the desired
miRNA and pCL-Ampho plasmid (RetroMax). Supernatants were collected after
48 h, ﬁltered (0.45 mm) and added to Jurkat T cells. Cells were centrifuged (1,200 g,
2 h) and incubated for 6 h at 37 C. Medium was replaced with RPMI, and GFP-
expressing cells were selected using ﬂow cytometry sorting.
RNA isolation. Total RNA was extracted with QIAzollysis reagent (Qiagen) and
the miRNeasy mini kit (Qiagen) and was screened for purity and concentration in a
Nanodrop-1000 Spectrophotometer (Thermo Scientiﬁc). RNA integrity was
assessed by ethidium bromide labeling on a 1.5% agarose gel.
Reverse transcription and quantitative real-time PCR. cDNA was synthesized
and mature miRNAs were quantiﬁed with miRCURY LNA Universal RT micro-
RNA PCR (Exiqon), using miRNA LNA primers (Exiqon) and SYBRgreen PCR
master mix (Applied Biosystems). PCR reactions were performed in triplicate in
10ml volumes in 384-well plates. Quantitative miRNA expression data were
acquired and analysed using the ABI Prism 7900HT Sequence Detection System
(Applied Biosystems). Data were further analysed using BiogazelleQBasePlus
software (Biogazelle). In relative PCR quantiﬁcations, RNU1A1 and RNU5G were
used as endogenous controls and results are expressed in arbitrary units. In
absolute PCR quantiﬁcations 10-fold dilutions of synthetic RNA oligonucleotides
(Exiqon) at known concentrations were reverse-transcribed and ampliﬁed, and the
absolute amount of each miRNA was calculated from the standard curve. A total of
108 copies of synthetic spike-in RNA (Exiqon) were also added to each sample for
normalization between samples. EXO/CL ratios were calculated by dividing the
number of copies in exosomes by the number of copies in cells.
Overexpression. Jurkat cells were transfected with hnRNPA2B1-GFP (Origene)
by electroporation. Cells were resuspended in Opti-MEM (GIBCO; 5 107 cells
per ml) with 30 mg of DNA plasmid and electroporated with Gene PulserXcell
(Bio-Rad) at 1,200 mFa, 240mV for 30ms in 4mm Bio-Rad cuvettes (Bio-Rad),
and hnRNPA2B1-GFP-positive cells were FACS-sorted. HEK 293T cells were
co-transfected with SUMO-1-HIS (kindly provided by Dr G. Bossis, IGMM
Montpellier) and hnRNPA2B1-GFP (Origene) or GFP-turbo by Lipofectamine-
2000 (Invitrogen) according to the manufacturer’s instructions.
Silencing. Jurkat cells were transfected twice (48 h apart) with a pool of double-
stranded siRNAs targeting hnRNPA2B1 (forward 50-GCAAGACCUCAUUCAAU
UGUU-30 , reverse 50-CCAUUGAAUGAGGUCUUGCUU-30 ; forward 50-GAACA
AUGGGGAAAGCUUAUU-30, reverse 50-UAAGCUUUCCCCAUUGUUCUU-30 ;
forward 50-GUUCAGAGUUCUAGGAGUCUU-30 , reverse 50-CACUCCUAGA
ACUCUGAACUU-30 ; forward 50-GAAGAGUAGUUGAGCCAAAUU-30 , reverse
50-UUUGGCUCAACUACUCUUCUU-30) (Eurogentec). Control cells were
transfected with a control siRNA (forward 50-AAUUCUCCGAACGUGUCAC
GUUU-30 , reverse 50-ACGUGACACGUUCGGAGAAUUUU-30) (Eurogentec).
Cells were resuspended in Opti-MEM (GIBCO; 5 107 cells per ml) with 2 mM
siRNA and electroporated with Gene PulserXcell (Bio-Rad) at 240mV for 28ms in
4mm Bio-Rad cuvettes (Bio-Rad).
Flow cytometry analysis and sorting. Cell samples were analysed with a
FACSCanto ﬂow cytometer and FACSDiva software (BD Biosciences). Viable cells
were identiﬁed by propidium iodide exclusion. Cells were sorted on a FACSAria
ﬂow cytometer (BD Biosciences).
miRNA pull-down. Exosomes from human primary T cells were isolated, resus-
pended in 400ml buffer 1 and precleared by incubation with streptavidin–sepharose
beads (GE Healthcare) (1.5 h, 4 C). Biotinylated miRNAs or poly-A (20 nmol;
Dharmacon) were resuspended in TBS with RNAse inhibitor (40Uml 1; Invi-
trogen) and incubated with 40 ml streptavidin–sepharose beads (4 h, 4 C). Beads
were washed twice with TBS and incubated with lysates (O/N, 4 C). Beads were
washed six times in buffer 2. Protein loading buffer (Fermentas) was added and
beads were heated at 90 for 10min before proteomics analysis. See Supplementary
Methods for buffer compositions.
Protein identiﬁcation using mass spectrometry. Proteins were in-gel digested
using a previously described protocol45. Brieﬂy, 75ml of beads were suspended in
25 ml sample buffer and loaded in 2.8-cm-wide wells of an SDS–PAGE gel. The run
was stopped as soon as the front entered 3mm into the resolving gel; the protein
band was visualized with Coomassie staining, excised and digested overnight at
37 C with 60 ng ml 1 trypsin at 5:1 protein:trypsin (w/w) ratio in 50mM
ammonium bicarbonate, pH 8.8 containing 10% acetonitrile. The resulting tryptic
peptides were extracted by 1 h incubation in 12mM ammonium bicarbonate,
pH 8.8. TFA was added to a ﬁnal concentration of 1% and the peptides were ﬁnally
desalted on C18 Oasis cartridges and dried down. Peptide identiﬁcation using mass
spectrometry was performed as described46. Brieﬂy, the peptides were resuspended
and injected on a C-18 reversed phase nano-column (75 mm I.D. 25 cm,
Acclaim PepMap100, Thermo Scientiﬁc) and analysed in a continuous acetonitrile
gradient consisting of 0–43% B in 90min, 50–90% B in 1min (B¼ 90%
acetonitrile, 0.5% acetic acid). A ﬂow rate of ca. 300 nlmin 1 was used to elute
peptides from the reversed phase nanocolumn to an emitter nanospray needle for
real time ionization and peptide fragmentation on an LTQ XP Orbitrap mass
spectrometer (Thermo Fisher). An enhanced FT spectrum (30.000 resolution)
followed by MS/MS spectra from most intense 10 parent ions were performed
along the chromatographic run (130min). Dynamic exclusion was set at 30 s. The
MS/MS raw ﬁles were searched against the Human Swissprot database (Uniprot
release 14.0, 19929 sequence entries for human) supplemented with porcine trypsin
and bacterial Streptavidin. SEQUEST results were validated using the probability
ratio method47 and false discovery rates were calculated using the reﬁned
method48. Peptide and scan-counting was performed assuming as positive events
those with a FDR equal to or lower than 5%.
Immunoprecipitation. A total of 3 107 cells were lysed in 1ml of buffer 4 and
incubated for pre-clearing with pre-washed Protein G Dynabeads (Invitrogen)
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(50 ml per condition) (1 h, 4 C). A total of 50 ml of Dynabeads were washed
twice in buffer 3, and resuspended in 200ml of buffer 3 containing 10 mg mouse
anti-hnRNPA2B1 (Santa Cruz), rabbit anti-GFP-turbo (Pierce), or mouse anti-IgG
control (Santa Cruz), and incubated 1 h at room temperature. Pre-cleared lysates
were incubated with Ab-conjugated Dynabeads (1.5 h, 4 C). Ab-conjugated
Dynabeads were washed twice with buffer 4, three times with buffer 5, transferred
to clean tubes and washed with buffer 6. Protein Loading buffer (Fermentas) was
added, samples were boiled at 95 C for 5min and processed for immunoblotting.
Immunoblotting. Cells or exosomes were lysed in lysis buffer (25mM Tris pH8,
150mM NaCl, 2mM MgCl2, 0.5%NP-40,) containing a protease inhibitor cocktail
(Complete, Roche). Proteins were separated on 10% acrylamide/bisacrylamide gels
and transferred to a nitrocellulose membrane. Membranes were incubated with
speciﬁc primary antibodies (5mgml 1) and peroxidase-conjugated secondary
antibodies (5mgml 1), and proteins were visualized with LAS-3000. The following
antibodies were used: mouse anti-hnRNPA1 (R4528, Sigma) (1:1,000), mouse anti-
hnRNPA2B1 (sc-53531, Santa Cruz) (1:200), goat anti-SUMO1 (sc-6376, Santa
Cruz) (1:200), mouse anti-SUMO1 (ab93951, Abcam) (1:1,000), goat anti-mouse
peroxidase (31446, Thermo Scientiﬁc) (1:5,000) and goat anti-rabbit peroxidase
(37460, Thermo Scientiﬁc) (1:5,000). Band intensities were quantiﬁed with Image
Gauge. Full blots are shown in Supplementary Fig. S8.
Immunoprecipitation–qPCR. Protein G Dynabeads (50 ml per condition) (Invi-
trogen) were washed twice in buffer 3 and resuspended in 200 ml of buffer 3
containing 10mg mouse anti-hnRNPA2B1 (Santa Cruz) or mouse anti-IgG control
(Santa Cruz) and incubated overnight at 4 C. Exosomes were isolated, resus-
pended in cold PBS and UV-crosslinked (120mJ cm 2 at 254 nm) (Stratalinker
UV crosslinker, Stratagene). Crosslinked exosomes were ultracentrifugated, lysed
by resuspension in buffer 4 and incubated (1 h, 4 C) with non-conjugated
Dynabeads (50 ml per condition). The precleared lysates were incubated with 50 ml
of Ab-conjugated Dynabeads (1.5 h, 4 C), which were then washed twice with
buffer 4 and three times with buffer 5, and transferred to clean tubes and washed
with buffer 6. For protein detection, Protein Loading buffer (Fermentas) was
added, and samples were boiled at 70 C for 10min and processed for immuno-
blotting. For qPCR analysis, 700 ml of Qiazol lysis reagent (Qiagen) were added and
samples were vortexed. See Supplementary Methods for buffer compositions.
Electrophoresis mobility shift assay. Biotinylated miRNAs or poly-A (1 nmol)
(Dharmacon) were incubated (when indicated) with 3 mg puriﬁed human
hnRNPA2B1 protein (Origene) in electrophoresis mobility shift assay (EMSA)
buffer (20min at room temperature). EMSA was performed with the Light Shift
Chemiluminescent EMSA kit (Pierce).
FACS analysis of exosome-coupled beads. Exosomes were obtained using
ultracentrifugation and sucrose gradient ﬂotation, resuspended in PBS and coupled
to 4 mm aldehyde-sulfate beads (Invitrogen) overnight at room temperature in
rotation. Beads were washed and blocked for 60min at room temperature in 4%
bovine serum albumin in PBS. For intracellular staining, bead-bound exosomes
were permeabilized and ﬁxed for 5min at room temperature with 0.2% Triton
X-100, 2% formaldehyde in PBS. Beads were incubated with anti-hnRNPA2B1
(Santa Cruz) or anti-CD81 (5A6, Santa Cruz) for 1 h at 4 C, washed and incubated
with Alexa-488-goat-anti-mouse IgG (Invitrogen) for 30min. Beads were acquired
on a FACSCalibur (BD) and data were analysed with FlowJo software (Tree Star).
Negative controls were obtained with exosome-coupled beads incubated with
the secondary antibody.
Sumoylation inhibition. Cells were cultured with AA (100 mM) (Sigma) or DMSO
for 4 h at 37 C. Cells were then diluted 1:4 and incubated overnight. Exosomes and
cells were resuspended in buffer 1 for western blotting or hnRNPA2B1
immunoprecipitation.
Statistical analysis. All statistical analyses were performed with Prism GraphPad.
Statistical signiﬁcance was calculated by nonparametric two-tailed Student’s t-test.
When making multiple statistical comparisons on a single data set one-way
ANOVA was used.
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